Tender for the provision of Aseptic Isolator systems and associated services

Concepts

• plymouth
• pharmaceutical products
• aseptic isolator systems
• pharmacy aseptic unit
• two new positive pressure isolator systems
• aseptic isolator
• aseptically
• aseptic
• isolator
• particular cancer chemotherapy treatment preparation

Location

Plymouth

Description

Tender for the provision of Aseptic Isolator systems and associated services

Total Quantity or Scope

A new Pharmacy Aseptic Unit (PAU) building will be located at the Estover site of UHP. The facility will be a stand-alone new build on an existing plot built between the warehouse and staff car park. This PAU shall provide a facility suitable to be licensed by the Medicines and Healthcare Product Regulatory Agency (MHRA) for the processing and production of aseptically prepared products for the Trust and external customers, in particular cancer chemotherapy treatment preparation (cytotoxic), but also a range of general intravenous preparations (IV) and Parenteral Nutrition (PN). Additionally, new gene therapy products that will require its own dedicated and segregated suite. This tender is for the requirements for the supply, installation, commissioning, and validation and maintenance of three new negative pressure and two new positive pressure isolator systems, that will comply with the current Good Manufacturing Practice (GMP) requirements as described by the Medicines and Healthcare Products Regulatory Agency (MHRA).

Renewal Options

The design, prototype and manufacturing is proposed to commence 31/10/2024, with supply from 10/01/2026 the contract will then run for 7 years with an option to extend for up to a further 3 years to 2036.

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Bids should cover the whole contract.
• Renewals are available.
• Staff qualifications are relevant.
• Award on basis of price and quality.